Specifically, reconstituted HDL particles, mainly apoA-I and phosphatidylcholine, could effectively decrease neutrophil activation and adhesion in type 2 diabetes and peripheral vascular disease patients. The gene discussed is APOA1; the disease is type 2 diabetes mellitus.